Search This Blog

Wednesday, February 26, 2020

Arena Pharmaceuticals EPS misses by $0.22, beats on revenue

Arena Pharmaceuticals (NASDAQ:ARNA): Q4 GAAP EPS of -$1.76 misses by $0.22.
Revenue of $3M (-65.5% Y/Y) beats by $1.44M.
Press Release
https://seekingalpha.com/news/3546026-arena-pharmaceuticals-eps-misses-0_22-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)